Form 8-K
Material Company Update
2026-04-03
ABBV filed 8-K — material company event
AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Latest SEC filings for AbbVie Inc. (ABBV) explained in plain English: insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). Sourced directly from SEC EDGAR.
AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Quaggin Susan E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
RAPP EDWARD J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Alpern Robert J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Purdue David Ryan, listed as SVP, Controller at AbbVie Inc., reported an open-market sale of 5,230 ABBV shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
David R. Purdue filed a Form 144 with the SEC indicating intent to sell ABBV (AbbVie Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
Crum Demetris D (EVP, CHIEF HR OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Thakkar Roopal (EVP, R&D and CSO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Michael Robert A. (Director, CHAIRMAN OF THE BOARD AND CEO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Stewart Jeffrey Ryan (EVP, CHIEF COMMERCIAL OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Siatis Perry C, listed as EVP, GC AND SECRETARY at AbbVie Inc., reported an open-market sale of 18,668 ABBV shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Reents Scott T (EVP, CHIEF FINANCIAL OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Purdue David Ryan (SVP, Controller) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
SALEKI-GERHARDT AZITA (EVP, CHIEF OPERATIONS OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.